Finite-course ocrelizumab in relapsing multiple sclerosis: Results of two prospective open-label trials with matched controls

Authors

Institutions

Publication Details

Journal
Multiple Sclerosis Journal
Published
2025-09-19
DOI
https://doi.org/10.1177/13524585251375350
Citations
1
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
1.47
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Finite-course ocrelizumab in relapsing multiple sclerosis: Results of two prospective open-label trials with matched controls

Mahsa Ghajarzadeh, Bridget Morris, Nicole Bou Rjeily, Emmanuelle L. Waubant et al.
1 citations
Multiple Sclerosis Journal
Multiple Sclerosis Research Studies
1.47
article

Finite-course ocrelizumab in relapsing multiple sclerosis: Results of two prospective open-label trials with matched controls

Mahsa Ghajarzadeh, Bridget Morris, Nicole Bou Rjeily, Emmanuelle L. Waubant, Alexandra Balshi, Andrea Salazar-Camelo, Bardia Nourbakhsh, Lauren Vega, Yasser Fadlallah, Ellen M Mowry
article en
1 citations

Abstract

No abstract available for this paper.
Multiple Sclerosis JournalVol. 31(11)
Johns Hopkins University (US), University of California, San Francisco (US)
Openalex Percentile: Top 15%
Multiple Sclerosis Research Studies
1.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.